In order to confirm that upregulation of ODZ1 was produced through binding of IL-6 to its cognate receptor, we cultured GBM cells in the presence of IL-6 and increasing concentrations of Tocilizumab, an anti-IL-6 receptor antibody that blocked binding to IL-615. Here, IL6 is linked to glioblastoma.